Clinical Trials Browser

Not yet recruiting × Esophageal Neoplasms × toripalimab × Clear all

NCT05996484 2023-08-21

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms